Viridian Therapeutics Inc. (VRDN)
Market Closed
17 Jul, 20:00
$
18. 03
0
0%
$
1.78B Market Cap
- P/E Ratio
- Div Yield
2.12M Volume
-4.96 Eps
$ 18.03
Previous Close 
Want to track VRDN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Viridian Therapeutics Inc. (VRDN) Statistics
Valuation metrics
Market Cap 1.78B
Enterprise value 1.5B
Trailing P/E (ttm) -5.18
Forward P/E -5.5
PEG ratio -1.18
Price/Sales (ttm) 22.88
Price/Book (mrq) 2.9
Enterprise Value/Revenue 21.12
Enterprise Value/EBITDA -4.29
Overview
Shares outstanding 101.83M
Float 102.15M
Shares short 10.66M
% Held by insiders 0%
% Held by institutions 1.07%
Average volume (10 days) 2.1M
Average volume (90 days) 2.89M
Price summary
52-Week low 13.18
52-Week high 34.29
Beta 1.17
50-Day moving average 17.45
200-Day moving average 23.87
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 13 Nov 2020
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -5.08%
Operating margin -5.44%
Operational effectiveness
Return on assets -0.46%
Return on equity -0.61%
Income Statement
Revenue (ttm) 70.85M
Revenue per share (ttm) 0.69
Quarterly revenue growth (yoy) 0.83%
Gross profit (ttm) -268.08M
EBITDA -362.94M
Net income to common (ttm) -281.93M
Diluted EPS (ttm) -3.53
Quarterly earnings growth (yoy) 0.83%
Balance Sheet
Total cash (mrq) 874.65M
Total cash per share (mrq) 7.46
Total debt (mrq) 52.59M
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 15.15%
Book value per share (mrq) 6.22
Cash Flow
Cash flow statement -276.39M
Levered free cash flow (LFCF) -162.07M
